Testing Services

Vacusera Crossmatch tubes contain silica particles as clot activator and K2EDTA / K3EDTA as anticoagulant.

Product Description EarlyTect Colon Cancer Test was approved by the Korea Ministry of Food and Drug Safety through clinical trials at Yonsei Medical Center, Severance Hospital, and Severance Check-up Center for eligible subjects, 585 men and women aged 30 to 80. Clinical trials using fecal DNA demonstrated that CRC can be diagnosed with 90% sensitivity and specificity. EarlyTect Colon Cancer Test is a qualitative real-time PCR test that measures methylated Syndecan-2, a biomarker clinically related to precancerous lesions of CRC, in stool DNA to diagnose colorectal cancer. This product is not intended to confirm colorectal cancer, so if a subject was positive, CRC or precancerous lesions of CRC may exist. Product Standard - Cancer Type: Colorectal Cancer - Subject: Subjects for asymptomatic colorectal cancer screening - Biomarker: SDC2 me The price and transaction conditions are negotiable. Please Request a Quote for the transaction

Applications and projects : integration of non-destructive testing equipment in an industrial environment Some practical examples : dimensional checks tomography 3D vision X-ray

Test station to review the gas detection devices. The control of the display accuracy 1Vol% - 2.2 Vol.% -100 Vol% -5 Vol.% CO2 is possible. All gases can be connected to 1 liter aluminum compressed gas cans. If larger quantities of gas are required, a steel pressure gas bottle can also be connected via an adapter and the pre-pressure reducer. With flow measurement. The test gas is conditioned (humidified)